Please Wait.....
Report
Mouth Ulcer Treatment - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2025 - 2030)
Market Report I 2025-07-02 I 113 Pages I Mordor Intelligence
Mouth Ulcer Treatment Market Analysis
The mouth ulcer treatment market generated USD 1.69 billion in 2025 and is forecast to reach USD 2.05 billion by 2030, advancing at a 3.89% CAGR. Moderate expansion reflects a maturing landscape in which well-established corticosteroid and analgesic brands face new competition from AI-guided personalization, herbal actives, and muco-adhesive films. Demand is reinforced by growing autoimmune disease prevalence, wider e-commerce access to over-the-counter (OTC) remedies, and a steady pipeline of delivery-system innovations. Market participants also contend with cost pressure as generic erosion accelerates and subscription-commerce models reset consumer expectations. While premium formulations command higher unit revenues in North America and Western Europe, emerging economies focus on affordable sprays and gels that deliver rapid pain relief and minimal systemic exposure.
Global Mouth Ulcer Treatment Market Trends and Insights
Rise in Sugar-Free & Herbal OTC Gels
Consumers increasingly choose plant-derived and sugar-free gels, pushing manufacturers to invest in botanical actives such as eugenol and flavonoids that pair well with modern muco-adhesive bases. Clinical validation supports efficacy, addressing regulatory and prescriber scrutiny. Market leaders differentiate through transparent labeling, clinical dossiers, and convenient packaging aligned with tele-pharmacy growth.
Growing Prevalence of Autoimmune Disorders
Enhanced and aging demographics lift autoimmune disease incidence, increasing oral lichen planus and aphthous ulcer cases. Targeted small-molecule therapies, illustrated by tofacitinib success in erosive lichen planus, shift treatment from broad anti-inflammatory regimens to precision approaches. Cross-portfolio synergies emerge as systemic immunology pipelines adapt topical formulations for oral lesion
OTC Product Commoditization Keeps Prices Low
Patent expiries and biosimilar entry drop average selling prices by nearly 50%, limiting premium scope unless backed by clear clinical or convenience advantages. Manufacturers lengthen life-cycles through reformulations, but retailers use private-label parity to restrain shelf prices.
Other drivers and restraints analyzed in the detailed report include:
E-commerce Proliferation Boosting Self-Medication / Advances in Muco-Adhesive Drug-Delivery Films / Safety Concerns Over Long-Term Corticosteroid Use /
For complete list of drivers and restraints, kindly check the Table Of Contents.
Segment Analysis
Analgesics retained 38.78% of the mouth ulcer treatment market in 2024, benefiting from physician familiarity and broad OTC access. The segment's lead, however, is challenged as anesthetics log a 4.15% CAGR, reflecting patient preference for rapid numbness that supports daily function. Combination nanofiber platforms delivering acyclovir plus clobetasol demonstrate superior lesion resolution, underlining the role of co-formulations in the mouth ulcer treatment market.
In revenue terms, anesthetic expansion translates into a rising contribution to the mouth ulcer treatment market size, propelled by dentistry partnerships and digital triage apps that advise immediate symptomatic relief. Corticosteroid brands remain indispensable for immune-mediated ulcers despite safety debate, while antimicrobial agents occupy niche use against secondary infection.
The Mouth Ulcer Treatment Market Report Segments the Industry Into Drug Class (Antimicrobial, Antihistamine, Analgesics, Corticosteroids, Other Drug Classes), Formulation (Sprays, Mouthwash, Gels, Other Formulations), Indication (Aphthous Stomatitis, Oral Lichen Planus, Other Indications) and Geography (North America, Europe, Asia-Pacific, Middle East and Africa and More). The Market Forecasts are Provided in Terms of Value (USD).
Geography Analysis
North America contributed 38.89% of 2024 value through robust insurance coverage, specialist networks, and marketing scale. Retail pharmacies increasingly co-pack AI-guided consultation leaflets, reinforcing premium positioning. The United States posts the highest per-capita spend, while Canada's reimbursement reforms encourage expanded OTC usage.
Asia-Pacific registers the top 5.63% CAGR through 2030, driven by urbanization, oral health campaigns, and regulatory streamlining in China and India. Beijing's 2027 reform blueprint promises faster review cycles, likely accelerating innovative spray and film launches. Malaysia's National Oral Health Strategic Plan further underscores regional policy focus on mouth ulcer prevention and early treatment. Local manufacturing hubs reduce cost, supporting volume penetration.
Europe sustains steady growth as evidence-based guidelines promote clinically proven products. Cross-border e-pharmacy directives foster online share gains, although strict advertising codes cap direct-to-consumer promotional flexibility. Market access hinges on health-technology-assessment outcomes that reward real-world evidence for novel delivery systems.
List of Companies Covered in this Report:
GlaxoSmithKline / Colgate-Palmolive Company / Sun Pharmaceuticals Industries / Pfizer / Blistex / Church & Dwight / Bristol-Myers Squibb / Taro Pharmaceutical Industries Ltd. / Bausch Health / 3M / Teva Pharmaceutical Industries / Reckitt Benckiser Group / Novartis / Sanofi / Prestige Consumer Healthcare / EUSA Pharma / Himalaya / Dr. Reddy's Laboratories Ltd. / Johnson & Johnson Consumer Health / Procter & Gamble / Dexcel Pharma /
Additional Benefits:
The market estimate (ME) sheet in Excel format /
3 months of analyst support /
1 Introduction
1.1 Study Assumptions & Market Definition
1.2 Scope of the Study
2 Research Methodology
3 Executive Summary
4 Market Landscape
4.1 Market Overview
4.2 Market Drivers
4.2.1 Rise in sugar?free & herbal OTC gels
4.2.2 Growing prevalence of autoimmune disorders
4.2.3 E-commerce proliferation boosting self-medication
4.2.4 Advances in muco-adhesive drug-delivery films (2025+)
4.2.5 AI-driven personalised oral-care regimens
4.2.6 Microbiome-targeted therapeutics pipeline
4.3 Market Restraints
4.3.1 OTC product commoditisation keeps prices low
4.3.2 Safety concerns over long-term corticosteroid use
4.3.3 Regulatory hurdles for novel biologic topicals
4.3.4 Under-diagnosis in low-income regions
4.4 Value / Supply-Chain Analysis
4.5 Regulatory Landscape
4.6 Technological Outlook
4.7 Porter's Five Forces
4.7.1 Bargaining Power of Buyers
4.7.2 Bargaining Power of Suppliers
4.7.3 Threat of New Entrants
4.7.4 Threat of Substitutes
4.7.5 Competitive Rivalry
4.8 Pricing Analysis
5 Market Size & Growth Forecasts (Value)
5.1 By Drug Class
5.1.1 Analgesics
5.1.2 Corticosteroids
5.1.3 Antimicrobials
5.1.4 Antihistamines
5.1.5 Anesthetics
5.1.6 Other Drug Classes
5.2 By Formulation
5.2.1 Ointments & Creams
5.2.2 Gels
5.2.3 Mouthwashes & Rinses
5.2.4 Sprays
5.2.5 Lozenges
5.2.6 Other Formulations
5.3 By Ulcer Type
5.3.1 Aphthous Stomatitis
5.3.2 Oral Lichen Planus
5.3.3 Others
5.4 By Geography
5.4.1 North America
5.4.1.1 United States
5.4.1.2 Canada
5.4.1.3 Mexico
5.4.2 Europe
5.4.2.1 Germany
5.4.2.2 United Kingdom
5.4.2.3 France
5.4.2.4 Italy
5.4.2.5 Spain
5.4.2.6 Rest of Europe
5.4.3 Asia-Pacific
5.4.3.1 China
5.4.3.2 India
5.4.3.3 Japan
5.4.3.4 South Korea
5.4.3.5 Australia
5.4.3.6 Rest of Asia-Pacific
5.4.4 South America
5.4.4.1 Brazil
5.4.4.2 Argentina
5.4.4.3 Rest of South America
5.4.5 Middle East and Africa
5.4.5.1 GCC
5.4.5.2 South Africa
5.4.5.3 Rest of Middle East and Africa
6 Competitive Landscape
6.1 Market Concentration
6.2 Market Share Analysis
6.3 Company Profiles (includes Global level Overview, Market level overview, Core Segments, Financials as available, Strategic Information, Market Rank/Share for key companies, Products & Services, and Recent Developments)
6.3.1 GlaxoSmithKline plc
6.3.2 Colgate-Palmolive Company
6.3.3 Sun Pharmaceutical Industries Ltd.
6.3.4 Pfizer Inc.
6.3.5 Blistex Inc.
6.3.6 Church & Dwight Co., Inc.
6.3.7 Bristol-Myers Squibb Company
6.3.8 Taro Pharmaceutical Industries Ltd.
6.3.9 Bausch Health Companies Inc.
6.3.10 3M Company
6.3.11 Teva Pharmaceutical Industries Ltd.
6.3.12 Reckitt Benckiser Group plc
6.3.13 Novartis AG
6.3.14 Sanofi S.A.
6.3.15 Prestige Consumer Healthcare Inc.
6.3.16 EUSA Pharma
6.3.17 Himalaya Wellness Company
6.3.18 Dr. Reddy's Laboratories Ltd.
6.3.19 Johnson & Johnson Consumer Health
6.3.20 Procter & Gamble Company
6.3.21 Dexcel Pharma
7 Market Opportunities & Future Outlook
7.1 White-space & Unmet-Need Assessment
- Not Sure / Need Reassuring
- Confirm Content
-
Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:
Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.
Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.
Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.
-
- Sample Pages
-
With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.
It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.
To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Check for Alternatives
-
Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.
To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.
-
- Confirm Content
- Prices / Formats / Delivery
- Prices
-
All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.
Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Discounts
-
As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.
Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.
To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Available Currencies
-
Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.
Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.
To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.
-
- Licenses
-
License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Global Site License
-
The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.
It is important to note that this may exclude Parent Companies or Subsidiaries.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Formats
-
The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.
If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.
-
- Delivery
-
Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.
Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.
If a delay in delivery is expected you will be informed about it immediately.
-
- Shipping Charges
-
As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.
If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.
-
- Prices
- Ordering
- By Credit Card
-
We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.
Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.
For more information on PayU please visit: https://www.payu.pl/en/about-us
-
- By Money Transfer
-
If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.
With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.
-
- By Credit Card
- Security
- Website security
-
We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.
Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.
-
- Credit Card Security
-
We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.
PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.
-
- Website security